← Back to Search

Aerobic Exercise Intervention for Breast Cancer (ACTIVATE Trial)

N/A
Waitlist Available
Led By Kerryn W Reding, PhD, MPH, RN
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 24
Awards & highlights

ACTIVATE Trial Summary

This trial looks at whether different exercise programs can help improve fitness in breast cancer patients who have finished treatment.

Eligible Conditions
  • Breast Cancer

ACTIVATE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intervention Feasibility
Secondary outcome measures
Intervention Acceptability
Intervention Adherence
Intervention Safety: Adverse Events
+2 more
Other outcome measures
Abdominal Deposits of Fat
Anthropometrics (Height)
Anthropometrics (Hip Circumference)
+11 more

ACTIVATE Trial Design

3Treatment groups
Experimental Treatment
Group I: Control Group (digital exercise interventions)Experimental Treatment3 Interventions
After 24 weeks, patients receive a digital copy of the 12-week AE sessions and 12-week RE sessions and an outline of sessions for 24 weeks.
Group II: Arm II (resistance exercise)Experimental Treatment4 Interventions
Patients participate in RE sessions 3 times per week for 12 weeks. After 12-weeks, non-responders may participate in a further 12-weeks of combined AE and RE sessions, while responders continue participating in the RE sessions alone for an additional 12 weeks.
Group III: Arm I (aerobic exercise)Experimental Treatment3 Interventions
Patients participate in AE sessions 3 times per week for 12 weeks. After 12-weeks, non-responders participate in combined AE and RE sessions for an additional 12 weeks, while responders continue participating in the AE sessions alone for an additional 12 weeks.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,741 Previous Clinical Trials
1,847,739 Total Patients Enrolled
19 Trials studying Breast Cancer
3,226 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,665 Previous Clinical Trials
40,925,827 Total Patients Enrolled
939 Trials studying Breast Cancer
1,543,333 Patients Enrolled for Breast Cancer
Kerryn W Reding, PhD, MPH, RNPrincipal InvestigatorUniversity of Washington

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE Trial
Kerryn Reding 2022. "Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04667481.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top